Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$91,066,373
+$3,752,128 QoQ
Shares Held
870,449
+13.8% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 274 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,036,351,867 across 359 Biotechnology names. CELC ranks #39 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CELC
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,066,373 | 870,449 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $87,314,245 | 764,975 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $65,112,964 | 652,827 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $20,893,136 | 422,938 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $700,567 | 52,477 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $900,527 | 89,073 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,541,464 | 117,759 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,501,481 | 100,703 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $370,728 | 22,633 | Shares | Defined | 2024-08-13 | |
| 2023-12-31 | $200,235 | 13,743 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $128,718 | 14,083 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $154,488 | 14,070 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $462,531 | 45,125 | Shares | Defined | 2024-05-14 | |
| 2021-09-30 | $191,088 | 10,616 | Shares | Defined | 2022-01-20 | |
| No filing history on record for this holder in this stock. | ||||||